ABK Biomedical
@abkbiomedical.bsky.social
ABK is proud to share that the first Canadian patient has been successfully treated with Eye90 microspheres® as part of the Route90 clinical trial.
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
November 21, 2025 at 11:46 PM
ABK is proud to share that the first Canadian patient has been successfully treated with Eye90 microspheres® as part of the Route90 clinical trial.
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
A sincere thank you to Dr. Rajvot Dhatt, his outstanding team at Vancouver General Hospital, and all other contributors supporting this study.
Did you know it’s Interventional Oncology (IO) Awareness Week?
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO
October 29, 2025 at 1:40 AM
Did you know it’s Interventional Oncology (IO) Awareness Week?
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO
ABK Biomedical is proud to support & contribute to the growing field of IO with an innovative approach to radioembolization with Eye90 microspheres® and our Route90 clinical trial.
www.ioawareness.org
#IOAwarenessWeek #Y90 #IKnowIO